See R E, Chapman M A, Meshul C K
Department of Psychology, Washington State University, Pullman 99164.
Synapse. 1992 Oct;12(2):147-54. doi: 10.1002/syn.890120208.
The effects of chronic intermittent administration (7 months) of two neuroleptics, haloperidol (HAL) and raclopride (RAC), were compared using several different measures. Both drugs were administered weekly by subcutaneous injection at 7.0 mg/kg. Both neuroleptics consistently produced catalepsy throughout the treatment period, although HAL was generally more cataleptogenic than RAC. Assessment of dopamine (DA) release in the caudate putamen (CPu), through the use of in vivo microdialysis, showed that chronic HAL or RAC administration caused a prolonged decrease of DA release in response to a low dose of the DA D2 agonist quinpirole (0.03 mg/kg, sc). Injection of the muscarinic agonist pilocarpine (1.0 mg/kg, IP) did not have any significant within-group effects, although both neuroleptic treatment groups showed decreased DA release when compared to controls. Ultrastructural analysis of the dorsolateral CPu showed that both HAL and RAC treatment resulted in a significant increase in the number of perforated synapses, which contain a discontinuous density along the postsynaptic membrane. These results demonstrate that two different DA D2 receptor antagonists produce a similar effect on DA function and ultrastructural changes within the CPu following chronic, intermittent treatment.
使用几种不同的测量方法比较了两种抗精神病药物氟哌啶醇(HAL)和雷氯必利(RAC)慢性间歇性给药(7个月)的效果。两种药物均以7.0mg/kg的剂量每周皮下注射给药。在整个治疗期间,两种抗精神病药物均持续产生僵住症,尽管氟哌啶醇通常比雷氯必利更易引发僵住症。通过体内微透析评估尾状壳核(CPu)中的多巴胺(DA)释放,结果显示,长期给予氟哌啶醇或雷氯必利会导致低剂量DA D2激动剂喹吡罗(0.03mg/kg,皮下注射)引起的DA释放持续减少。注射毒蕈碱激动剂毛果芸香碱(1.0mg/kg,腹腔注射)在组内没有任何显著影响,尽管与对照组相比,两个抗精神病药物治疗组的DA释放均减少。对背外侧CPu的超微结构分析表明,氟哌啶醇和雷氯必利治疗均导致穿孔突触数量显著增加,穿孔突触在突触后膜上含有不连续的致密物。这些结果表明,两种不同的DA D2受体拮抗剂在慢性间歇性治疗后,对CPu内的DA功能和超微结构变化产生相似的影响。